Literature DB >> 17945513

Articular cartilage metabolism in patients with Kashin-Beck Disease: an endemic osteoarthropathy in China.

J Cao1, S Li, Z Shi, Y Yue, J Sun, J Chen, Q Fu, C E Hughes, B Caterson.   

Abstract

OBJECTIVE: The objective of this study was to investigate CD44 and proteoglycan metabolism in patients suffering from Kashin-Beck Disease (KBD), an endemic osteoarthropathy that affects 2.5 million of 30 million people living in the KBD regions of China.
METHODS: Immunohistochemical analyses of cluster of differentiation-44 (CD44), BC-13 and 3-B-3(-) expression were performed in cartilage sections harvested from KBD and normal patients. In addition, the serum levels of soluble CD44 (sCD44), interleukin-1beta (IL-1beta), tumor necrosis factor-alpha (TNF-alpha) and matrix metalloproteinase-1 were determined using a sandwich enzyme linked immunosorbent assay.
RESULTS: Hematoxylin & eosin and toluidine blue staining indicated that there was cell necrosis and proteoglycan loss in cartilage from both KBD children and adult cartilage. Strong immunohistochemical staining for CD44, BC-13 and 3-B-3(-) occurred in the majority of adult KBD patients and most KBD children. Furthermore, statistically significant elevated levels of sCD44, IL-1beta and TNF-alpha were found in the sera of both adult and child KBD patients when compared to the levels of normal adult and child controls. Interestingly, IL-1beta and TNF-alpha serum levels were all high in normal children from KBD regions when compared to normal children from non-KBD regions suggesting that unidentified factors (e.g., a genetic predisposition) may protect some people from KBD pathology.
CONCLUSION: Our results demonstrate that altered CD44, IL-1beta and TNF-alpha metabolism occurs in the pathogenesis of KBD and there is an increased aggrecanase-generated proteoglycan loss from KBD adult and child cartilage. These primary metabolic changes are likely to be significant contributing factor causing pathological joint formation and instability that leads to secondary osteoarthritis in KBD patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17945513     DOI: 10.1016/j.joca.2007.09.002

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  38 in total

1.  Serum levels of TNF-α, IL-1β, COMP, and CTX-II in patients with Kashin-Beck disease in Sichuan, China.

Authors:  Xin Tang; Zongke Zhou; Bin Shen; Jing Yang; Pengde Kang; Jian Li; Nicolas Crook; Qi Li; Li Min; Fuxing Pei
Journal:  Rheumatol Int       Date:  2011-11-09       Impact factor: 2.631

2.  Validation of the SF-12 among adult Kashin-Beck disease patients in Aba Tibetan autonomous area in China.

Authors:  Qiang Huang; Zong Ke Zhou; Bin Shen; Xiao Bo Yang; Yong Li; Peng De Kang; Jing Yang; Fu Xing Pei
Journal:  Rheumatol Int       Date:  2012-05-08       Impact factor: 2.631

3.  A randomized, single-blind comparison of the efficacy and tolerability of hyaluronate acid and meloxicam in adult patients with Kashin-Beck disease of the knee.

Authors:  Xin Tang; Fu-Xing Pei; Zong-Ke Zhou; Gang Liu; Bin Shen; Peng-De Kang; Jian Li; Xiao-Dan Zhao; Qi Li; Yong Li
Journal:  Clin Rheumatol       Date:  2012-04-03       Impact factor: 2.980

Review 4.  The effects of T-2 toxin on the prevalence and development of Kashin-Beck disease in China: a meta-analysis and systematic review.

Authors:  Danyang Li; Jing Han; Xiong Guo; Chengjuan Qu; Fangfang Yu; Xiaofang Wu
Journal:  Toxicol Res (Camb)       Date:  2016-02-18       Impact factor: 3.524

5.  Radiographic features of hand osteoarthritis in adult Kashin-Beck Disease (KBD): the Yongshou KBD study.

Authors:  Q Fu; J Cao; J B Renner; J M Jordan; B Caterson; V Duance; M Luo; V B Kraus
Journal:  Osteoarthritis Cartilage       Date:  2015-01-24       Impact factor: 6.576

6.  Effects of moniliformin and selenium on human articular cartilage metabolism and their potential relationships to the pathogenesis of Kashin-Beck disease.

Authors:  An Zhang; Jun-ling Cao; Bo Yang; Jing-hong Chen; Zeng-tie Zhang; Si-yuan Li; Qiang Fu; Clare E Hugnes; Bruce Caterson
Journal:  J Zhejiang Univ Sci B       Date:  2010-03       Impact factor: 3.066

7.  The long-term efficacy and tolerability of hyaluronic acid in adult patients with Kashin-Beck disease of the knee.

Authors:  Xin Tang; Zong-Ke Zhou; Gang Liu; Bin Shen; Peng-De Kang; Jian Li; Qi Li; Fu-Xing Pei
Journal:  Clin Rheumatol       Date:  2014-02-13       Impact factor: 2.980

8.  Reliability and validity of the 12-item WHODAS 2.0 in patients with Kashin-Beck disease.

Authors:  Mohammad Imran Younus; Di-Miao Wang; Fang-Fang Yu; Hua Fang; Xiong Guo
Journal:  Rheumatol Int       Date:  2017-04-24       Impact factor: 2.631

9.  Kashin Beck Disease: more than just osteoarthrosis: a cross-sectional study regarding the influence of body function-structures and activities on level of participation.

Authors:  Karin Schepman; Raoul H H Engelbert; Milanka M Visser; Changlong Yu; Rien de Vos
Journal:  Int Orthop       Date:  2010-06-11       Impact factor: 3.075

10.  Expression and localization of the small proteoglycans decorin and biglycan in articular cartilage of Kashin-Beck disease and rats induced by T-2 toxin and selenium deficiency.

Authors:  Mengying Wang; Senhai Xue; Qian Fang; Meng Zhang; Ying He; Ying Zhang; Mikko J Lammi; Junling Cao; Jinghong Chen
Journal:  Glycoconj J       Date:  2019-09-02       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.